Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Choosing an index fund for retirement involves comparing Sp500 vs total market exposure, costs, and long-term growth potential.
28,502 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
An executive chair's sizable stock sale draws attention. This piece explains what the numbers mean, how to read insid...
A clear, investor-friendly look at arcosa (aca) 2025 earnings through the lens of the Q4 2025 earnings call. Learn wh...
A clear read of SERA’s Q1 2026 numbers and management commentary can shift an investor’s view of 2026. This guide bre...
As a global health scare rises in prominence, investors quiz whether bitcoin can withstand another black swan shock. ...
SpaceX’s emergence as a top public company captures headlines, but sustainable value hinges on cash flow, strategy, a...
Two Harbors moved its special meeting to July 2 to push the CrossCountry Mortgage deal through, while a rival bid fro...
Morgan Stanley's 2026 outlook hinges on wealth management growth, trading environment, and disciplined capital manage...
In the first half of 2026, american superconductor corporation rallied as grid modernization and superconducting tech...
Despite fintech rivals, Western Union remains a durable money-movement platform with a vast network and steady cash f...
As AI workloads surge, memory becomes a key battleground. This guide breaks down Micron and Sandisk fundamentals, gro...
A bold investing thesis centers on a single nuclear stock with big plans for small modular reactors and recycled fuel...